January 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integral Ad Science Holding Corp. (“IAS” or “the Company”) (NASDAQ: IAS). Investors who purchased IAS securities prior to March 2, 2023, and continue to hold to the present, are encouraged to… read more
January 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arconic Corporation (“Arconic” or “the Company”) (NYSE: ARNC). Investors who purchased Arconic securities prior to April 19, 2022, and continue to hold to the present, are encouraged to obtain additional information… read more
January 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nextracker Inc. (“Nextracker” or “the Company”) (NASDAQ: NXT). Investors who purchased Nextracker securities prior to February 1, 2024, and continue to hold to the present, are encouraged to obtain additional information… read more
January 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Methode Electronics, Inc. (“Methode Electronics” or “the Company”) (NYSE: MEI). Investors who purchased Methode Electronics securities prior to December 2, 2021, and continue to hold to the present, are encouraged to… read more
January 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. (“Lifecore” or “the Company”) (NASDAQ: LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to obtain additional… read more
January 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. (“Globe Life” or “the Company”) (NYSE: GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to… read more
January 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sharecare Inc. (“Sharecare” or “the Company”) (NASDAQ: SHCR). Investors who purchased Sharecare securities prior to May 10, 2023, and continue to hold to the present, are encouraged to obtain additional information… read more
January 1, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innodata Inc. (“Innodata” or “the Company”) (NASDAQ: INOD). Investors who purchased Innodata securities prior to May 9, 2019, and continue to hold to the present, are encouraged to obtain additional information… read more
December 31, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ETHZilla Corporation (“ETHZilla” or “the Company”) (NASDAQ: ETHZ). Investors who purchased ETHZilla securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether ETHZilla has violated federal… read more
December 31, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bgin Blockchain Limited (“Bgin” or “the Company”) (NASDAQ: BGIN). Investors who purchased Bgin securities are encouraged to obtain additional information and assist the investigation. The investigation focuses on alleged violations of… read more
December 30, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Duluth Holdings Inc. (“Duluth” or “the Company”) (NASDAQ: DLTH). Investors who purchased Duluth securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Duluth has violated… read more
December 30, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Air Products and Chemicals, Inc. (“Air Products” or “the Company”) (NYSE: APD). Investors who purchased Air Products securities are encouraged to obtain additional information and assist the investigation. The investigation concerns… read more
December 30, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Air Products and Chemicals, Inc. (“Air Products” or “the Company”) (NYSE: APD). Investors who purchased Air Products securities are encouraged to obtain additional information and assist the investigation. The investigation concerns… read more
December 30, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Galectin Therapeutics Inc. (“Galectin” or “the Company”) (NASDAQ: GALT). Investors who purchased Galectin securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Galectin has violated… read more
December 24, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cogent Communications Holdings, Inc. (“Cogent” or “the Company”) (NASDAQ: CCOI). Investors who purchased Cogent securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Cogent has… read more
December 23, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Above Food Ingredients, Inc. (“Above Food” or “the Company”) (NASDAQ: ABVE). Investors who purchased Above Food securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
December 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Insmed Incorporated (“Insmed” or “the Company”) (NASDAQ: INSM). Investors who purchased Insmed securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Insmed has violated federal… read more
December 18, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bicycle Therapeutics plc (“Bicycle” or “the Company”) (NASDAQ: BCYC). Investors who purchased Bicycle securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Bicycle has violated… read more
December 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sarepta Therapeutics, Inc. (“Sarepta” or “the Company”) (NASDAQ: SRPT). Investors who purchased Sarepta securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sarepta has violated… read more
December 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ventyx Biosciences, Inc. (“Ventyx” or “the Company”) (NASDAQ: VTYX). Investors who purchased Ventyx securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Ventyx has violated… read more
December 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Waldencast plc (“Waldencast” or “the Company”) (NASDAQ: WALD). Investors who purchased Waldencast securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Waldencast has violated federal… read more
December 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Venu Holding Corporation (“Venu” or “the Company”) (NYSE: VENU). Investors who purchased Venu securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Venu has violated… read more
December 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Outset Medical, Inc. (“Outset Medical” or “the Company”) (NASDAQ: OM). Investors who purchased Outset Medical securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Outset… read more
December 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Baidu, Inc. (“Baidu” or “the Company”) (NASDAQ: BIDU). Investors who purchased Baidu securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Baidu has violated federal… read more
December 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PetMed Express, Inc. (“PetMed” or “the Company”) (NASDAQ: PETS). Investors who purchased PetMed securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether PetMed has violated… read more
December 8, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Balancer (“Balancer” or “the Company”) (Other: BAL). Investors who purchased Balancer securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Balancer has violated federal securities… read more
December 8, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PagerDuty, Inc. (“PagerDuty” or “the Company”) (NYSE: PD). Investors who purchased PagerDuty securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether PagerDuty has violated federal… read more
December 3, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Home Depot, Inc. (“Home Depot” or “the Company”) (NYSE: HD). Investors who purchased Home Depot securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
December 3, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Village Farms International, Inc. (“Village Farms” or “the Company”) (NASDAQ: VFF). Investors who purchased Village Farms securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
December 1, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RCI Hospitality Holdings, Inc. (“RCI” or “the Company”) (NASDAQ: RICK). Investors who purchased RCI securities prior to December 15, 2021, and continue to hold to the present, are encouraged to obtain… read more